A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV | ACS Infectious Diseases
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules | Journal of Medicinal Chemistry
![Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...](https://pubs.acs.org/cms/10.1021/jm0490641/asset/images/large/jm0490641n00001.jpeg "Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...")
Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...
COVID-19: Drug Targets and Potential Treatments | Journal of Medicinal Chemistry
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor | Journal of Medicinal Chemistry
Role of Inflammatory Processes in Hemorrhagic Stroke | Stroke
Viruses | Free Full-Text | A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction | Scientific Reports
Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine | ACS Nano
Synthetic Strategies toward SGLT2 Inhibitors | Organic Process Research & Development
Polymeric particle-based therapies for acute inflammatory diseases | Nature Reviews Materials
IJMS | Free Full-Text | Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
Full article: Emerging PEGylated non-biologic drugs
Frontiers | Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects
Cold fusion - Wikipedia
Drug Discovery Targeting Bromodomain-Containing Protein 4 | Journal of Medicinal Chemistry
Advances in Antiviral Material Development - Liang - 2020 - ChemPlusChem - Wiley Online Library
IJMS | Free Full-Text | To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Microorganisms | Free Full-Text | How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?
Using NMR Spectroscopy in the Fragment‐Based Drug Discovery of Small‐Molecule Anticancer Targeted Therapies - Diethelm‐Varela - 2021 - ChemMedChem - Wiley Online Library
Catalysts | Free Full-Text | Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019)
Frontiers | Challenges and Opportunities for the Large-Scale Chemoenzymatic Glycoengineering of Therapeutic N-Glycosylated Monoclonal Antibodies
